Bioimpedance Devices Market

Bioimpedance Devices to gain Increased Acceptance for Minimally-invasive Cancer Detection has announced the addition of a report, titled “Bioimpedance Devices Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018 – 2028”. The report offers in-depth insights into the key growth dynamics, the factors underpinning emerging avenues, recent technological advancements, and the prevailing competitive dynamics. The study takes a closer look at the trends underpinning product innovations for various end-users such as hospitals, specialty clinics, and rehabilitation centers.

A key factor driving the global bioimpedance devices market is the rising epidemic of obesity in various countries across the world. The rising health concerns of co-morbid health concerns, notably cardiovascular risks, is another vital factor propelling the demand for bioimpedance devices for identify these. Moreover, these devices are witnessing demand in-vivo diagnostics.

A great deal of momentum to the global bioimpedance devices market has come from the growing use of devices in cancer detection in the global healthcare systems. Bioimpedance devices have gained wide acceptance in detecting various types of cancer, notably prostate cancer, breast cancer, and cervical cancer. Substantial morbidity and mortality these cancer types bring to the patient populations are fueling the rapid growth in the market.

The global bioimpedance devices market is benefitting from the growing adoption of non-invasive diagnostics in the healthcare sector. The characteristic of rapid result generation from such screening is a key proposition bolstering their acceptance in patient populations, especially in primary care centers.

The staggering rise in numbers of wellness centers in developing economies imparts a large momentum to the market’s growth. The rising number of sports rehabilitation centers is a notable factor boosting the bioimpedance devices market. The trends has picked steam from the growing awareness of people about their physical appearance. The rising number of people visiting weight loss clinics and growing demand for sports rehabilitation are factor boosting the market.

The rapid pace of digitization in the healthcare sector in developing and developed regions is offering an increasing impetus to the global bioimpedance devices market. In developing regions, the growth is fueled to a great extent by governments’ efforts in advancing healthcare infrastructure and growing investment in healthcare IT.

You can get free access to samples from the report here:

Rising healthcare spending on improving healthcare standards is a key factor boosting the market. Meanwhile, in developed countries, technological advancements in bioimpedance devices are opening new waves of innovation. The advent of smart needles is a case in point.

Some of the well-entrenched players in the global bioimpedance devices market are Bodystat Limited, RJL Systems, Inc., Tanita Corporation, ImpediMed Limited, Fresenius Medical Care, Omron Corporation, and General Electric Company. Some of the key regional segments in the market are North America, Japan, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, and the Middle East and Africa.

Leave a Reply

Your email address will not be published. Required fields are marked *